STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7

Clinical trials for STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7 explained in plain language.

Never miss a new study

Get alerted when new STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7 trials appear

Sign up with your email to follow new studies for STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to Re-Sensitize tough thyroid cancers to standard treatment

Disease control Ongoing

This study is testing if adding an oral drug called trametinib can make radioactive iodine treatment work again for people with advanced thyroid cancer that has spread or come back and no longer responds to iodine. The goal is to see if trametinib helps the cancer absorb more iod…

Matched conditions: STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7

Get alerted when new STAGE IVC THYROID GLAND PAPILLARY CARCINOMA AJCC V7 trials appear

New drug combo aims to Re-Sensitize tough thyroid cancers to standard treatment